Correlation Between Eliem Therapeutics and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Nuvalent, you can compare the effects of market volatilities on Eliem Therapeutics and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Nuvalent.
Diversification Opportunities for Eliem Therapeutics and Nuvalent
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Eliem and Nuvalent is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Nuvalent go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Nuvalent
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 1.26 times less return on investment than Nuvalent. In addition to that, Eliem Therapeutics is 1.79 times more volatile than Nuvalent. It trades about 0.03 of its total potential returns per unit of risk. Nuvalent is currently generating about 0.08 per unit of volatility. If you would invest 3,156 in Nuvalent on August 29, 2024 and sell it today you would earn a total of 6,474 from holding Nuvalent or generate 205.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 99.6% |
| Values | Daily Returns |
Eliem Therapeutics vs. Nuvalent
Performance |
| Timeline |
| Eliem Therapeutics |
| Nuvalent |
Eliem Therapeutics and Nuvalent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Nuvalent
The main advantage of trading using opposite Eliem Therapeutics and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Nuvalent vs. Eliem Therapeutics | Nuvalent vs. Scpharmaceuticals | Nuvalent vs. Milestone Pharmaceuticals | Nuvalent vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |